Literature DB >> 15001300

The public health response to a case of Lassa fever in London in 2000.

N S Crowcroft1, M Meltzer, M Evans, N Shetty, H Maguire, M Bahl, R Gair, N Brink, D Lockwood, S Gregor, J Jones, A Nicoll, R Gopal, D Brown, B Bannister.   

Abstract

OBJECTIVES: Evaluation of the Department of Health 1996 guidance, the Memorandum on the Management and Control of Viral Haemorrhagic Fevers.
METHODS: Description of the public health management in 2000 of the fifth UK patient confirmed to have Lassa fever.
RESULTS: Delayed risk categorisation of the patient occurred for a variety of reasons. DH Guidance was followed once infection control advice was sought. Active surveillance of 125 contacts was extremely resource intense, involving over 3000 communications. Self-monitoring by healthcare workers should be considered in future. Advice on use of ribavirin prophylaxis is not included in the Memorandum, nor advice or templates for information sheets for contacts. Information sheets are now available from the Health Protection Agency in the event of future cases. International aspects not adequately addressed include the need for reliable risk assessment to be carried out before patients are medically evacuated from the country of origin, and the steps required to repatriate UK nationals. Effective and efficient communication is required between national and international organisations involved in such incidents.
CONCLUSIONS: If guidelines are unclear or impracticable they will not be followed. It is important that lessons are learned and documented and that national guidance be regularly reviewed.

Entities:  

Mesh:

Year:  2004        PMID: 15001300     DOI: 10.1016/j.jinf.2003.11.009

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  11 in total

1.  Ribavirin for Lassa fever postexposure prophylaxis.

Authors:  Christiane M Hadi; Augustine Goba; Sheik Humarr Khan; James Bangura; Mbalu Sankoh; Saffa Koroma; Baindu Juana; Alpha Bah; Mamadou Coulibaly; Daniel G Bausch
Journal:  Emerg Infect Dis       Date:  2010-12       Impact factor: 6.883

2.  Imported Lassa fever: a report of 2 cases in Ghana.

Authors:  Nicholas N A Kyei; Mark M Abilba; Foster K Kwawu; Prince G Agbenohevi; Joseph H K Bonney; Thomas K Agbemaple; Shirley C Nimo-Paintsil; William Ampofo; Sally-Ann Ohene; Edward O Nyarko
Journal:  BMC Infect Dis       Date:  2015-05-29       Impact factor: 3.090

3.  Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of lassa fever.

Authors:  Giovanni Lo Iacono; Andrew A Cunningham; Elisabeth Fichet-Calvet; Robert F Garry; Donald S Grant; Sheik Humarr Khan; Melissa Leach; Lina M Moses; John S Schieffelin; Jeffrey G Shaffer; Colleen T Webb; James L N Wood
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

Review 4.  Diagnostics in Ebola Virus Disease in Resource-Rich and Resource-Limited Settings.

Authors:  Robert J Shorten; Colin S Brown; Michael Jacobs; Simon Rattenbury; Andrew J Simpson; Stephen Mepham
Journal:  PLoS Negl Trop Dis       Date:  2016-10-27

5.  The risk of transmission of a viral haemorrhagic fever infection in a United Kingdom laboratory.

Authors:  Robert J Shorten; Eleri Wilson-Davies
Journal:  PLoS Negl Trop Dis       Date:  2017-05-18

6.  A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks-results from the Lassa fever pilot.

Authors:  Louise Sigfrid; Catrin Moore; Alex P Salam; Nicola Maayan; Candyce Hamel; Chantelle Garritty; Vittoria Lutje; Brian Buckley; Karla Soares-Weiser; Rachel Marshall; Mike Clarke; Peter Horby
Journal:  BMC Med       Date:  2019-06-11       Impact factor: 8.775

Review 7.  Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.

Authors:  Daniel G Bausch; Christiane M Hadi; Sheik Humarr Khan; Juan J L Lertora
Journal:  Clin Infect Dis       Date:  2010-11-08       Impact factor: 9.079

Review 8.  Hemorrhagic fever viruses.

Authors:  David C Pigott
Journal:  Crit Care Clin       Date:  2005-10       Impact factor: 3.598

Review 9.  Guidance for contact tracing of cases of Lassa fever, Ebola or Marburg haemorrhagic fever on an airplane: results of a European expert consultation.

Authors:  Andreas Gilsdorf; Dilys Morgan; Katrin Leitmeyer
Journal:  BMC Public Health       Date:  2012-11-21       Impact factor: 3.295

10.  Lassa Fever in Travelers from West Africa, 1969-2016.

Authors:  Aaron Kofman; Mary J Choi; Pierre E Rollin
Journal:  Emerg Infect Dis       Date:  2019-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.